Saraiva, D.P.; Azeredo-Lopes, S.; Antunes, A.; Salvador, R.; Borralho, P.; Assis, B.; Pereira, I.L.; Seabra, Z.; Negreiros, I.; Jacinto, A.;
et al. Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer. Cancers 2021, 13, 3841.
https://doi.org/10.3390/cancers13153841
AMA Style
Saraiva DP, Azeredo-Lopes S, Antunes A, Salvador R, Borralho P, Assis B, Pereira IL, Seabra Z, Negreiros I, Jacinto A,
et al. Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer. Cancers. 2021; 13(15):3841.
https://doi.org/10.3390/cancers13153841
Chicago/Turabian Style
Saraiva, Diana P., Sofia Azeredo-Lopes, Ana Antunes, Rute Salvador, Paula Borralho, Beatriz Assis, Isabel L. Pereira, Zita Seabra, Ida Negreiros, António Jacinto,
and et al. 2021. "Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer" Cancers 13, no. 15: 3841.
https://doi.org/10.3390/cancers13153841
APA Style
Saraiva, D. P., Azeredo-Lopes, S., Antunes, A., Salvador, R., Borralho, P., Assis, B., Pereira, I. L., Seabra, Z., Negreiros, I., Jacinto, A., Braga, S., & Cabral, M. G.
(2021). Expression of HLA-DR in Cytotoxic T Lymphocytes: A Validated Predictive Biomarker and a Potential Therapeutic Strategy in Breast Cancer. Cancers, 13(15), 3841.
https://doi.org/10.3390/cancers13153841